Friday, July 10, 2026
🇺🇸 FDA

pharma · Hepatitis C Virus Infection · Chronic Hepatitis B

Gilead Sciences Ireland

Gilead Sciences Ireland UC

Gilead Sciences Ireland clinical programs — 26 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Website Investor relations
333 Lakeside Drive, Foster City, CA 94404, US HQ
1987 Founded
14,602 Employees
EMA registrant Type
Company details
Status
Public
HQ
333 Lakeside Drive, Foster City, CA 94404, US
Founded
1987
Employees
14,602
Programs
26
Drugs
17
Patents
0
Official website ↗ All projects Drug pipeline News & analysis
Intelligence · Clinical Programs

Gilead Sciences Ireland projects

26 ClinicalTrials.gov programs sponsored by Gilead Sciences Ireland.

Gilead Sciences Ireland has 26 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

All phases Phase III Phase II Phase I NDA / BLA filed Approved programs

26 programs

Clinical programs

  1. AZLI 75 mg two times a day (BID)/ three times a day (TID)

    Gilead Sciences Ireland UC

    Cystic Fibrosis

    phase 3 small molecule completed

    1 trial

  2. B/F/TAF

    Gilead Sciences Ireland UC

    HIV-1/HBV Co-Infection

    phase 3 small molecule completed

    1 trial

  3. B/F/TAF (Adult Strength)

    Gilead Sciences Ireland UC

    HIV-1 Infection

    phase 3 small molecule active

    1 trial

  4. Bictegravir

    Gilead Sciences Ireland UC

    HIV-1-infection

    phase 3 small molecule active

    2 trials

  5. COBI

    Gilead Sciences Ireland UC

    HIV

    phase 3 small molecule completed

    1 trial

  6. E/C/F/TDF

    Gilead Sciences Ireland UC

    Acquired Immunodeficiency Syndrome

    phase 3 small molecule completed

    1 trial

  7. LDV/SOF

    Gilead Sciences Ireland UC

    Hepatitis C Virus

    phase 3 small molecule completed

    1 trial

  8. SOF/VEL

    Gilead Sciences Ireland UC

    Hepatitis C Virus Infection

    phase 3 small molecule completed

    3 trials

  9. SOF/VEL/VOX

    Gilead Sciences Ireland UC

    Hepatitis C Virus Infection

    phase 3 small molecule completed

    1 trial

  10. Sacituzumab Govitecan-hziy

    Gilead Sciences Ireland UC

    Triple Negative Breast Cancer

    phase 3 small molecule active

    1 trial

  11. Sofosbuvir

    Gilead Sciences Ireland UC

    Chronic HCV Infection

    phase 3 small molecule completed

    1 trial

  12. Sofosbuvir

    Gilead Sciences Ireland UC

    Hepatitis C

    phase 3 small molecule completed

    2 trials

  13. Tenofovir DF

    Gilead Sciences Ireland UC

    Chronic Hepatitis B

    phase 3 small molecule active

    1 trial

  14. Andecaliximab

    Gilead Sciences Ireland UC

    Crohn's Disease

    phase 2 small molecule terminated

    1 trial

  15. BSF 208075

    Gilead Sciences Ireland UC

    Pulmonary Hypertension

    phase 2 small molecule completed

    1 trial

  16. Presatovir

    Gilead Sciences Ireland UC

    Respiratory Syncytial Virus

    phase 2 small molecule completed

    1 trial

  17. SOF

    Gilead Sciences Ireland UC

    HCV Infection

    phase 2 small molecule completed

    1 trial

  18. SOF

    Gilead Sciences Ireland UC

    Hepatitis C Virus Infection

    phase 2 small molecule completed

    1 trial

  19. VOX

    Gilead Sciences Ireland UC

    Hepatitis C Virus Infection

    phase 2 small molecule completed

    1 trial

  20. B/F/TAF

    Gilead Sciences Ireland UC

    HIV-1-infection

    phase 1 small molecule completed

    1 trial

  21. Evixapodlin

    Gilead Sciences Ireland UC

    Advanced Solid Tumors

    phase 1 small molecule terminated

    1 trial

  22. GS-0272

    Gilead Sciences Ireland UC

    Rheumatoid Arthritis

    phase 1 small molecule active

    1 trial

  23. GS-2829

    Gilead Sciences Ireland UC

    Chronic Hepatitis B

    phase 1 mab completed

    1 trial

  24. Lanraplenib.

    Gilead Sciences Ireland UC

    Inflammatory Disease

    phase 1 small molecule completed

    1 trial

  25. SOF/VEL/VOX

    Gilead Sciences Ireland UC

    HCV Infection

    phase 1 small molecule completed

    1 trial

  26. TDF

    Gilead Sciences Ireland UC

    Chronic Hepatitis B

    approved small molecule completed

    1 trial

Frequently asked questions

How many clinical projects does Gilead Sciences Ireland have?

26 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.